| A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas (NCT05475925) | Dren Bio | 2022-07-13 |
| Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002) (NCT05233618) | Karen Ballen, MD | 2022-07-13 |
| A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017) (NCT05511558) | LeonaBio | 2022-07-13 |
| A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate (NCT05469854) | Cinclus Pharma Holding AB | 2022-07-13 |
| Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma (NCT05019716) | National Cancer Institute (NCI) | 2022-07-13 |
| A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies (NCT05362773) | MacroGenics | 2022-07-13 |
| A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants (NCT06294288) | Longbio Pharma | 2022-07-13 |
| A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors (NCT05389462) | ADC Therapeutics S.A. | 2022-07-13 |
| A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-548 (NCT05455502) | Vertex Pharmaceuticals Incorporated | 2022-07-13 |
| TMLI and Alemtuzumab for Treatment of Sickle Cell Disease (NCT05384756) | City of Hope Medical Center | 2022-07-13 |
| HMPL-523 Food Effect and Proton Pump Inhibitor Study (NCT05571787) | Hutchmed | 2022-07-13 |
| FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) (NCT05432193) | POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | 2022-07-13 |
| A Study of Elpipodect (MK-8189) in Participants With Schizophrenia (MK-8189-014) (NCT05406440) | Merck Sharp & Dohme LLC | 2022-07-12 |
| AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease (NCT05452304) | AstraZeneca | 2022-07-12 |
| B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme (NCT05474378) | Stanford University | 2022-07-12 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of TCMCB07 in Single and Multiple Ascending Doses in Health Subjects (NCT05529849) | Endevica Bio | 2022-07-12 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants (NCT05405543) | Bristol-Myers Squibb | 2022-07-12 |
| A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) (NCT05487170) | Ranok Therapeutics (Hangzhou) Co., Ltd. | 2022-07-12 |
| Human Mass Balance and Biotransformation Study of [14C]TNP-2198 (NCT06137573) | TenNor Therapeutics (Suzhou) Limited | 2022-07-12 |
| A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis (NCT05453942) | Sanofi | 2022-07-12 |
| A Study of Belzutifan (MK-6482) in Participants With Renal Impairment (MK-6482-021) (NCT04994522) | Merck Sharp & Dohme LLC | 2022-07-12 |
| A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps (NCT05324137) | Keymed Biosciences Co.Ltd | 2022-07-11 |
| A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02) (NCT05460273) | AstraZeneca | 2022-07-11 |
| Topical Ruxolitinib in Chronic Hand Dermatitis (NCT05293717) | University of Rochester | 2022-07-11 |
| Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease (NCT05447494) | CANbridge (Suzhou) Bio-pharma Co., Ltd. | 2022-07-11 |
| A Study of Single Ascending Dose of LEM-S401 in Healthy Participants (NCT04707131) | Lemonex Inc. | 2022-07-11 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers (NCT05844787) | Mthera Pharma Co., Ltd. | 2022-07-11 |
| Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults (NCT05398796) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-07-11 |
| Topical Absorption of Glutathione-cyclodextrin Complex in Healthy Human Subjects Improves Immune Response Against Mycobacterium Infection (NCT05926245) | Western University of Health Sciences | 2022-07-11 |
| A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors (NCT05329103) | Peel Therapeutics Inc | 2022-07-11 |
| OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer (NCT05232136) | Binhui Biopharmaceutical Co., Ltd. | 2022-07-11 |
| Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects (NCT05478772) | Concert Pharmaceuticals | 2022-07-11 |
| Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors (NCT05270213) | Riboscience, LLC. | 2022-07-11 |
| A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers (NCT05364164) | Celltrion | 2022-07-09 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar (NCT05434897) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2022-07-08 |
| Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists (NCT05463133) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-07-08 |
| A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants (NCT05445232) | Eli Lilly and Company | 2022-07-08 |
| A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines (NCT05434585) | Suzhou Abogen Biosciences Co., Ltd. | 2022-07-08 |
| A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma (NCT04769869) | AstraZeneca | 2022-07-08 |
| Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors (NCT05839106) | Biotheus Inc. | 2022-07-08 |
| A Phase I Study to Evaluate the Safety and PK of ND-340 in Healthy Volunteers (NCT05588557) | Nang Kuang Pharmaceutical Co., Ltd. | 2022-07-08 |
| Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers (NCT05449704) | Dong-A ST Co., Ltd. | 2022-07-08 |
| Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics (NCT05448651) | Upstream Bio Inc. | 2022-07-08 |
| Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer (NCT05113537) | Vadim S Koshkin | 2022-07-08 |
| A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies (NCT05338346) | Antengene Discovery Limited | 2022-07-08 |
| A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS (NCT05448599) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-07-08 |
| A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors (NCT06873542) | Heronova Pharmaceuticals | 2022-07-08 |
| THC Memory & Reward Learning Pilot (NCT05116527) | Hartford Hospital | 2022-07-07 |
| Safety, Tolerability and Pharmacodynamics of SYNB1353 in Healthy Adult Volunteers (NCT05462132) | Synlogic | 2022-07-07 |
| Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder (NCT04982796) | Portland VA Research Foundation, Inc | 2022-07-07 |
| CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma (NCT05458180) | Tianjin Medical University Cancer Institute and Hospital | 2022-07-07 |
| Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants (NCT06394518) | TenNor Therapeutics Inc. | 2022-07-07 |
| Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE) (NCT05377281) | Craig van Horne, MD, PhD | 2022-07-07 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of FHND5071 as a Single Agent in Adult Patients With Advanced Solid Tumors (NCT05818917) | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 2022-07-07 |
| A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors (NCT06245330) | Ascentawits Pharmaceuticals, Ltd | 2022-07-07 |
| A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults (NCT05397119) | BlueWillow Biologics | 2022-07-07 |
| A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers (NCT04926324) | University of Iowa | 2022-07-07 |
| A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002) (NCT05394350) | Merck Sharp & Dohme LLC | 2022-07-07 |
| Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153) | National Cancer Institute (NCI) | 2022-07-07 |
| A Study of Imlunestrant (LY3484356) in Female Healthy Participants (NCT05444556) | Eli Lilly and Company | 2022-07-07 |
| Spinal Cord Injury Neuroprotection With Glyburide (NCT05426681) | Francis Farhadi | 2022-07-07 |
| To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects (NCT05413161) | Kashiv BioSciences, LLC | 2022-07-07 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants (NCT05477095) | Vaxxinity, Inc. | 2022-07-06 |
| A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Aluvia (NCT07002242) | Henan Genuine Biotech Co., Ltd. | 2022-07-06 |
| A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors (NCT05381909) | BeiGene | 2022-07-06 |
| A Study of TRK-950 in Patients With Advanced Solid Tumors (NCT05423262) | Toray Industries, Inc | 2022-07-06 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI (NCT05152290) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-07-06 |
| SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation (NCT05480865) | Navire Pharma Inc., a BridgeBio company | 2022-07-06 |
| Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection (NCT05378737) | Bio-Thera Solutions | 2022-07-06 |
| SV2A in Older Adults (NCT05465538) | Yale University | 2022-07-06 |
| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) (NCT04897321) | St. Jude Children's Research Hospital | 2022-07-06 |
| The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia (NCT05315661) | Samsung Medical Center | 2022-07-06 |
| NF-1, Nutraceutical Intervention (NCT05363267) | Masonic Cancer Center, University of Minnesota | 2022-07-06 |
| ALSENLITE: Senolytics for Alzheimer's Disease (NCT04785300) | Mayo Clinic | 2022-07-06 |
| A Study to Assess Safety of Cedirogant and How Cedirogant Moves Through the Body in Adult Participants With Mild, Moderate and Severe Hepatic Impairment (NCT05376839) | AbbVie | 2022-07-06 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091) | National Cancer Institute (NCI) | 2022-07-06 |
| TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals (NCT05275998) | TaiMed Biologics Inc. | 2022-07-05 |
| Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. (NCT05389267) | Laboratoires Thea | 2022-07-05 |
| Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects (NCT05415644) | Shandong Suncadia Medicine Co., Ltd. | 2022-07-05 |
| Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL (NCT05296525) | Gamida Cell ltd | 2022-07-05 |
| A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function (NCT05440344) | Eli Lilly and Company | 2022-07-05 |
| Evaluate IMG-007 in Healthy Participants (NCT05353972) | Inmagene LLC | 2022-07-05 |
| First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALT-100 (NCT05426746) | Aqualung Therapeutics Corp. | 2022-07-05 |
| Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population (NCT05966324) | AstraZeneca | 2022-07-05 |
| A Study of MG-K10 in Subjects With Asthma (NCT05382910) | Shanghai Mabgeek Biotech.Co.Ltd | 2022-07-05 |
| Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial Cancer (NCT05332483) | Sunnybrook Health Sciences Centre | 2022-07-05 |
| A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. (NCT05355701) | Pfizer | 2022-07-05 |
| Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia (NCT04982354) | Guenther Koehne | 2022-07-05 |
| Study of INCB123667 in Subjects With Advanced Solid Tumors (NCT05238922) | Incyte Corporation | 2022-07-05 |
| A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease (NCT05398029) | Verve Therapeutics, Inc. | 2022-07-05 |
| BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers (NCT05466734) | Genovate Biotechnology Co., Ltd., | 2022-07-05 |
| A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma (NCT05205161) | AstraZeneca | 2022-07-05 |
| Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy (NCT05198882) | Assistance Publique - Hôpitaux de Paris | 2022-07-04 |
| A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas (NCT05415072) | Novartis Pharmaceuticals | 2022-07-04 |
| A Study in Healthy Men to Test How BI 456906 is Processed in the Body (NCT05421338) | Boehringer Ingelheim | 2022-07-04 |
| Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients (NCT06095375) | Istituto Oncologico Veneto IRCCS | 2022-07-04 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis (NCT05016804) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-07-04 |
| A Single and Multiple Ascending Dose Study of JNJ-64457744 (NCT05423106) | Janssen Research & Development, LLC | 2022-07-04 |
| A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects (NCT05440006) | Jiangsu HengRui Medicine Co., Ltd. | 2022-07-03 |
| A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants (NCT05458076) | Qilu Pharmaceutical Co., Ltd. | 2022-07-03 |